Development and Validation of a Combined Ferroptosis and Immune Prognostic Model for Melanoma

Figure 5

CIFI Cox analysis and nomogram model development. (a) Univariate Cox analysis of OS in the TCGA dataset. (b) Multivariate Cox analysis of OS in the TCGA dataset. (c) A nomogram model that incorporates CIFI and conventional clinical characteristics. (d) The nomogram model’s 5-year calibration curves. (e) DCA (decision curve analysis) of the nomogram model.

(a)

(b)

(c)

(d)

(e)